However, experimental models that mimic the unique immunological characteristics upon HBV and HCV infection as well as the development of late stage liver diseases, would greatly facilitate our understanding of CXCR5+ CD8+ T cells for the treatment of infected patients. Here, CD8A is linked to liver disorder.